Holen Sie sich die Stockscreener-App
30.31
0.49%
-0.15
Handel nachbörslich:
30.33
0.02
+0.07%
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
Schrodinger stock hits 52-week high at 31.69 USD By Investing.com - Investing.com Australia
Price to book forward of Schrodinger, Inc. – HAN:43Z - TradingView
ETFs Investing in Schrodinger, Inc. Stocks - TradingView
These ten healthcare stocks posted the biggest September gains - TradingView
43Z.SG Interactive Stock Chart | Schrodinger Inc. Stock - Yahoo Finance
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View - Yahoo Finance
Schrodinger Stock Price Forecast. Should You Buy SDGR? - StockInvest.us
Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - TradingView
Schrödinger stock falls 4.79 percent as ACV growth reaches 27 percent - AD HOC NEWS
Schrödinger Drops 7.6% Amid Sector-Wide Selling - AlphaStreet
A Look at Schrodinger Inc (SDGR) After 4.8% Decline -- GF Value $24.26 vs Price $29.23 - GuruFocus
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs - inkl
Precision Trading with Schrodinger Inc. (SDGR) Risk Zones - Stock Traders Daily
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Layoff Tracker: Novo workforce down 13,000 - BioSpace
Schrodinger stock gains 69.1 percent year to date - AD HOC NEWS
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance
Schrodinger Inc. (SDGR) Pulls Back 4.03% to $29.02, Nearing Key SupportReversal Setup Alerts - siam.in
SDGR Q2 2026 Earnings: EPS Swings to Profit, Beating Estimates by 116%Estimate Revision Count - careplusvn.com
Schrödinger, Inc. Partners with NEA and RA Capital Management to Co-Found Tectora - Labroots
Schrodinger Inc. (SDGR) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Schrodinger Inc (SDGR) Shares Fall 4.0% -- GF Value Says Still O - GuruFocus
Schrödinger options flow points to bullish positioning ahead of potential catalyst - Investing.com
Schrodinger Inc (SDGR) Stock Up 26.4% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Schrödinger (SDGR) Stock Surges 60% but $37 Resistance Could Test the Rally as Mixed Fundamentals Raise Fresh Risks - FXLeaders
Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan
Schrödinger (SDGR) Surges 13.5% to $27.15 - AlphaStreet
$Schrodinger (SDGR.US)$ what happened?[Blush] - Moomoo
Schrödinger: Company Creation Is Now The Real Drug Business (NASDAQ:SDGR) - Seeking Alpha
SDGR Looks 3.2% Undervalued on GF Value™ - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Schrödinger (SDGR) Rallies On Tectora Deal But Is The Upside Already Priced In - simplywall.st
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock? - finance.yahoo.com
SDGR Looks 5.9% Undervalued on GF Value™ as AI-Driven Surge Lifts Shares - GuruFocus
Schrödinger jumps 12% to new 52-week high amid AI drug-discovery interest (SDGR:NASDAQ) - Seeking Alpha
Schrodinger Inc stock hits 52-week high at 23.06 USD By Investing.com - Investing.com Australia
Schrodinger Inc stock hits 52-week high at 23.06 USD - Investing.com
SDGR: AI-driven platform innovation and hosted solutions fuel growth, with profitability targeted by 2028 - TradingView
Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily
Schrödinger introduces Tectora Therapeutics - BioWorld News
Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace
SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com
A new drug company raises $55 million for oral medicines - Stock Titan
Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics - Fierce Biotech
Is Schrodinger Inc (SDGR) a Bargain After 3.1% Drop? GF Value Sa - GuruFocus
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportPut Flow Alert - dars.gov.et
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? - TradingView
“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty - Yahoo Finance
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - PR Newswire
Schrödinger’s Strait - الحرة
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Drug Discovery Platforms Market to Reach USD 16.5 Billion by 2036, Driven by AI-Powered Research and Rising Pharmaceutical R&D Investment - industrytoday.co.uk
0.13%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):